<DOC>
	<DOCNO>NCT00092690</DOCNO>
	<brief_summary>This study ass safety efficacy investigational drug compare approve drug reduce specific cholesterol level .</brief_summary>
	<brief_title>MK0653A ( Ezetimibe ( + ) Simvastatin ) Compared Approved Drug ( Atorvastatin ) Treatment High Cholesterol ( 0653A-051 ) ( COMPLETED )</brief_title>
	<detailed_description>The duration treatment 6 week .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Elevated cholesterol Unstable medical condition significant heart problem within 3 month prior first study visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>